191 related articles for article (PubMed ID: 21039420)
1. Melanocortins protect against multiple organ dysfunction syndrome in mice.
Bitto A; Polito F; Altavilla D; Irrera N; Giuliani D; Ottani A; Minutoli L; Spaccapelo L; Galantucci M; Lodi R; Guzzo G; Guarini S; Squadrito F
Br J Pharmacol; 2011 Feb; 162(4):917-28. PubMed ID: 21039420
[TBL] [Abstract][Full Text] [Related]
2. Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway.
Minutoli L; Bitto A; Squadrito F; Irrera N; Rinaldi M; Nicotina PA; Arena S; Magno C; Marini H; Spaccapelo L; Ottani A; Giuliani D; Romeo C; Guarini S; Antonuccio P; Altavilla D
Endocrinology; 2011 Oct; 152(10):3852-61. PubMed ID: 21828180
[TBL] [Abstract][Full Text] [Related]
3. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.
Giuliani D; Mioni C; Bazzani C; Zaffe D; Botticelli AR; Capolongo S; Sabba A; Galantucci M; Iannone A; Grieco P; Novellino E; Colombo G; Tomasi A; Catania A; Guarini S
Br J Pharmacol; 2007 Mar; 150(5):595-603. PubMed ID: 17245369
[TBL] [Abstract][Full Text] [Related]
4. NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.
Ottani A; Giuliani D; Neri L; Calevro A; Canalini F; Vandini E; Cainazzo MM; Ruberto IA; Barbieri A; Rossi R; Guarini S
Eur J Pharmacol; 2015 Dec; 769():22-32. PubMed ID: 26477637
[TBL] [Abstract][Full Text] [Related]
5. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke.
Ottani A; Giuliani D; Mioni C; Galantucci M; Minutoli L; Bitto A; Altavilla D; Zaffe D; Botticelli AR; Squadrito F; Guarini S
J Cereb Blood Flow Metab; 2009 Mar; 29(3):512-23. PubMed ID: 19018269
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest.
Ottani A; Neri L; Canalini F; Calevro A; Rossi R; Cappelli G; Ballestri M; Giuliani D; Guarini S
Eur J Pharmacol; 2014 Dec; 745():108-16. PubMed ID: 25446929
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regulation of hypothalamic neuropeptide gene expression and food intake by melanocortin analogues and reversal with melanocortin-4 receptor antagonist.
Kim RY; Shin SW; Kim BJ; Lee W; Baik JH
Biochem Biophys Res Commun; 2005 Apr; 329(4):1178-85. PubMed ID: 15766551
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway.
Minutoli L; Squadrito F; Nicotina PA; Giuliani D; Ottani A; Polito F; Bitto A; Irrera N; Guzzo G; Spaccapelo L; Fazzari C; Macrì A; Marini H; Guarini S; Altavilla D
Crit Care Med; 2011 May; 39(5):1089-96. PubMed ID: 21263321
[TBL] [Abstract][Full Text] [Related]
9. α-MSH analogue attenuates blood pressure elevation in DOCA-salt hypertensive mice.
Rinne P; Penttinen AM; Nordlund W; Ahotupa M; Savontaus E
PLoS One; 2013; 8(8):e72857. PubMed ID: 23977363
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery.
Giuliani D; Zaffe D; Ottani A; Spaccapelo L; Galantucci M; Minutoli L; Bitto A; Irrera N; Contri M; Altavilla D; Botticelli AR; Squadrito F; Guarini S
Acta Neuropathol; 2011 Oct; 122(4):443-53. PubMed ID: 21927944
[TBL] [Abstract][Full Text] [Related]
11. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism.
Ottani A; Giuliani D; Galantucci M; Spaccapelo L; Novellino E; Grieco P; Jochem J; Guarini S
Eur J Pharmacol; 2010 Jul; 637(1-3):124-30. PubMed ID: 20385118
[TBL] [Abstract][Full Text] [Related]
12. Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s disease.
Giuliani D; Galantucci M; Neri L; Canalini F; Calevro A; Bitto A; Ottani A; Vandini E; Sena P; Sandrini M; Squadrito F; Zaffe D; Guarini S
Eur J Pharmacol; 2014 Oct; 740():144-50. PubMed ID: 25034807
[TBL] [Abstract][Full Text] [Related]
13. NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors.
Giuliani D; Neri L; Canalini F; Calevro A; Ottani A; Vandini E; Sena P; Zaffe D; Guarini S
Mol Cell Neurosci; 2015 Jul; 67():13-21. PubMed ID: 26003413
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ.
Tatro JB; Entwistle ML
Brain Res; 1994 Jan; 635(1-2):148-58. PubMed ID: 8173950
[TBL] [Abstract][Full Text] [Related]
15. Melanocortin MC₄ receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia.
Spaccapelo L; Bitto A; Galantucci M; Ottani A; Irrera N; Minutoli L; Altavilla D; Novellino E; Grieco P; Zaffe D; Squadrito F; Giuliani D; Guarini S
Eur J Pharmacol; 2011 Nov; 670(2-3):479-86. PubMed ID: 21946115
[TBL] [Abstract][Full Text] [Related]
16. Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome.
Volman TJ; Goris RJ; van der Meer JW; Hendriks T
Ann Surg; 2004 Jul; 240(1):142-50. PubMed ID: 15213630
[TBL] [Abstract][Full Text] [Related]
17. Melanocortin 4 receptor activation protects striatal neurons and glial cells from 3-nitropropionic acid toxicity.
Saba J; Carniglia L; Ramírez D; Turati J; Imsen M; Durand D; Lasaga M; Caruso C
Mol Cell Neurosci; 2019 Jan; 94():41-51. PubMed ID: 30529228
[TBL] [Abstract][Full Text] [Related]
18. Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes.
Wang SC; Myers SA; Eriksson NA; Fitzsimmons RL; Muscat GE
Mol Endocrinol; 2011 Feb; 25(2):291-306. PubMed ID: 21239615
[TBL] [Abstract][Full Text] [Related]
19. NDP-MSH treatment recovers marginal lungs during ex vivo lung perfusion (EVLP).
Lonati C; Battistin M; Dondossola DE; Bassani GA; Brambilla D; Merighi R; Leonardi P; Carlin A; Meroni M; Zanella A; Catania A; Gatti S
Peptides; 2021 Jul; 141():170552. PubMed ID: 33865932
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.
Jansen MJ; Hendriks T; de Man BM; van der Meer JW; Goris RJ
Cytokine; 1999 Sep; 11(9):713-21. PubMed ID: 10479408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
